Form 4: TransMedics Group Director Acquires Shares and Stock Options

Director Thomas James Gunderson acquired 732 shares of common stock and 1,154 stock options in TransMedics Group, Inc. on May 23, 2024.

Summary

• On May 23, 2024, Thomas James Gunderson, a director of TransMedics Group, Inc., acquired 732 shares of common stock and 1,154 stock options.
• The 732 shares were acquired as restricted stock units (RSUs), each representing a contingent right to receive one share of the Issuer's common stock.
• The stock options have an exercise price of $137.53 and vest in full on the earlier of May 23, 2025, or the date of the 2025 annual meeting of stockholders, subject to continued service.
• Following the transaction, Gunderson directly owns 1,925 shares of common stock and 1,154 stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing reflecting insider transactions. The acquisition of shares and options by a director is mildly positive, suggesting confidence, but it's not a major event.

Positives

• The acquisition of shares and stock options by a director could be seen as a positive sign, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This filing indicates changes in the beneficial ownership of TransMedics Group, Inc. securities by one of its directors.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as it indicates a director's investment in the company.

Key Dates